Renal insufficiency is highly prevalent among cancer patients, which negatively impacts on their survival. Furthermore, many oncological treatments may severely impair kidney function or exasperate preexisting renal diseases.
Thus, the relationship between cancer and the kidney could be regarded as “circular” and warrants specific competencies and expertise for its management.
This is why onco-nephrology, as a subspecialty of both oncology and nephrology, has begun to gain importance over the past few years.
The complex issues of the management of cancer patients in dialysis, of candidates for kidney transplantation who have had a previous malignancy, and of transplant recipients who subsequently develop a malignancy, also fall into the field of onco-nephrology.
Launay-VacherVOudardSJanusNet al;Renal Insufficiency and Cancer Medications (IRMA) Study Group. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer200711061376–1384
2.
JanusNOudardSBeuzebocP. Prevalence of renal insufficiency in cancer patients: data from the IRMA-2 study. J Clin Oncol20092715s9559
3.
HuangWCLeveyASSerioAM. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol200679735–740
4.
JanusNLaunay-VacherVByloosE. Cancer and renal insufficiency results of the BIRMA study. Br J Cancer2010103121815–1821
5.
CanterDKutikovASirohiM. Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology2011774781–785
6.
NakamuraYTsuchiyaKNittaKAndoMPrevalence of anemia and chronic kidney disease in cancer patients: clinical significance for 1-year mortality. Nihon Jinzo Gakkai Shi201153138–45
7.
KönigsbrüggeOLötschFZielinskiCPabingerIAyCChronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality. Thromb Res2014134144–49
8.
ChenJWangXTLuoPHHeQJEffects of unidentified renal insufficiency on the safety and efficacy of chemotherapy for metastatic colorectal cancer patients: a prospective, observational study. Support Care Cancer20152341043–1048
9.
LichtmanSMCirrincioneCTHurriaA. Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907. J Clin Oncol2016347699–705
10.
CockcroftDWGaultMHPrediction of creatinine clearance from serum creatinine. Nephron197616131–41
11.
LeveyASBoschJPLewisJBGreeneTRogersNRothDA more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med19991306461–470
12.
HolwegerKLippHPDietzKHartmannJTBokemeyerCNovel algorithm for more accurate calculation of renal function in adults with cancer. Ann Pharmacother200842121749–1757
13.
KleberMCybullaMBauchmüllerKIhorstGKochBEngelhardtMMonitoring of renal function in cancer patients: an ongoing challenge for clinical practice. Ann Oncol2007185950–958
14.
Launay-VacherVChatelutELichtmanSMWildiersHSteerCAaproMInternational Society of Geriatric Oncology. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations. Ann Oncol20071881314–1321
15.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis2002392 Suppl 1S1–S266
16.
LeveyASEckardtKUTsukamotoY. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int20056762089–2100
17.
PortaCCosmaiLGallieniMPerazellaMAHarmonization of Renal Function Assessment Is Needed Throughout the Whole Process of Anticancer Drug Development. J Clin Oncol201634202429–30
18.
PortaCCosmaiLGallieniMPedrazzoliPMalbertiFRenal effects of targeted anticancer therapies. Nat Rev Nephrol2015116354–370
19.
CosmaiLPortaCGallieniMPerazellaMAOnco-nephrology: a decalogue. Nephrol Dial Transplant2016314515–519
20.
FrascàGMSandriniSCosmaiL. Renal cancer in kidney transplanted patients. J Nephrol2015286659–668
21.
Talseth-PalmerBAWijnenJTGriceDMScottRJGenetic modifiers of cancer risk in Lynch syndrome: a review. Fam Cancer2013122207–216
22.
RassKReichrathJUV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol2008624162–178
23.
ReichrathJRassKUltraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update. Adv Exp Med Biol2014810208–233
